Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT03340766

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Charleston, South Carolina, United States
  • Research Site Greenville, South Carolina, United States
  • Research Site Darlinghurst, New South Wales, Australia
View all 22 locations
View Trial Details
Completed

Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma

NCT02939183

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Research Site West Hollywood, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT)

NCT04372147

Conditions
At Risk of Post-operative Recurrence, Brain Diseases, Burr-hole Surgery, +20 more
Locations
  • Hôpital d'instruction des armées de Percy Clamart, France
  • Hôpital Beaujon Clichy, France
  • Hôpital Henri-Mondor Créteil, France
  • CHU Lille (Hôpital Roger Salengro) Lille, France
View Trial Details
Completed

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

NCT02616640

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 102 Baltimore, Maryland, United States
  • Local Institution - 114 Boston, Massachusetts, United States
  • Local Institution - 108 Boston, Massachusetts, United States
  • Local Institution - 115 Boston, Massachusetts, United States
View all 22 locations
View Trial Details

Related conditions